Martin J D, Hähnel R, McCartney A J, Woodings T L
Am J Obstet Gynecol. 1983 Oct 1;147(3):322-4. doi: 10.1016/0002-9378(83)91119-5.
This study demonstrates a significantly increased survival time for women with estrogen receptor-positive adenocarcinoma of the endometrium when compared with that of those with estrogen receptor-negative tumors (p less than 0.05). This prognostic factor provides information which is additional to, and independent of, that provided by the histologic grade and myometrial penetration of the tumor.
这项研究表明，与雌激素受体阴性肿瘤患者相比，雌激素受体阳性子宫内膜腺癌女性的生存时间显著延长（p小于0.05）。这个预后因素所提供的信息是肿瘤组织学分级和肌层浸润所提供信息之外的，且与之无关。
